Trials / Conditions / End-Stage Kidney Disease (ESKD)
End-Stage Kidney Disease (ESKD)
5 registered clinical trials studyying End-Stage Kidney Disease (ESKD) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Pharmacokinetics of Oral Letermovir in Adults With End-Stage Kidney Disease With or Without Haemodialysis NCT07101055 | Jason A Roberts | Phase 1 |
| Recruiting | DIALysis With EXpanded Solute Removal NCT06660277 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | N/A |
| Completed | The Safety and Effectiveness of Warfarin Vs Apixaban in Patients With NVAF/ VTE and ESKD on Dialysis NCT06606275 | Abu Dhabi Health Services Company | — |
| Completed | Single Dose Study of MK-2060 to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Ol NCT05769595 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1 NCT05832931 | Pathalys Pharma | Phase 3 |